to develop effective and safe treatments for cancer
At Candel Therapeutics, our team is developing oncolytic viral immunotherapies that light up and empower the immune system to fight cancer
Our viral-based approaches allow us to calibrate our immunotherapy treatments to each cancer that we target
Our viral immunotherapies are being designed to have favorable benefit-to-risk profiles, in an effort to ensure patients have efficacious and safe treatments across disease stages